VIVUS, Inc.
(Other OTC/NBB : VVUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.44%50.250.0%$736.34m
GWPHGW Pharmaceuticals Plc 0.35%215.006.1%$394.66m
HZNPHorizon Therapeutics Plc 0.42%91.305.5%$198.60m
JAZZJazz Pharmaceuticals Plc 0.09%168.202.3%$190.09m
VRXValeant Pharmaceuticals International, Inc. 1.97%32.0414.1%$188.53m
BHCBausch Health Cos., Inc. 1.91%32.020.0%$143.93m
CTLTCatalent, Inc. 3.31%117.472.1%$119.28m
ICLRICON plc -2.20%176.704.2%$94.00m
ARGXargenx SE 2.41%338.650.0%$83.77m
PRGOPerrigo Co. Plc 6.81%43.116.8%$76.64m
TNXPTonix Pharmaceuticals Holding Corp. 4.20%1.240.2%$69.42m
ZYNEZynerba Pharmaceuticals, Inc. 4.34%4.696.0%$61.32m
AMRNAmarin Corp. Plc -4.75%6.421.5%$46.96m
UTHRUnited Therapeutics Corp. 3.29%172.6914.1%$45.46m
PBHPrestige Consumer Healthcare, Inc. 2.04%42.564.0%$41.47m

Company Profile

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm’s products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.